Dibenzo[b,f]azocin-6(5H)-ones and Benzo[b]pyrido[2,3-f]azocin-5(6H)-ones: Useful Scaffolds for Development of Protein–Protein Interaction Inhibitors †
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27187998 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Michał Nowacki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Technology and Pharmaceutical Biotechnology, Medical University of Warsaw, Banacha 1, 02-097 Warszawa, Poland. Hauptthemen laut MEDLINE: Trypanocidal Agents. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki, Ruhr University Bochum, InnovationsFoRUM, Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
Modulation of protein–protein interactions (PPIs) by small molecules is a vital strategy in drug discovery. Nevertheless, due to the inherent nature of PPI interfaces, practical implementation of this approach remains a high-hanging fruit in medicinal chemistry. In this report, we develop a new line of PEX14–PEX5 PPI inhibitors by homologation of a previously developed dibenzo[b,e]azepin-6(6H)-one scaffold. The challenging chemistry of 8-membered ring formation led to the development of novel PEX14 inhibitors featuring a 6+8+6 tricyclic system. The obtained analogs were tested for their capability of disrupting the PEX5-TbPEX14 PPI, as well as for in vitro activity against the T. brucei protist. Overall, the developed scaffold not only represents an interesting alternative for prospective trypanocidal TbPEX14 ligands but may also be useful in the design of inhibitors of other PPIs mediated by a similar topology of hydrophobic binding pockets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Drug Technology and Pharmaceutical Biotechnology, Medical University of Warsaw, Banacha 1, 02-097 Warszawa, Poland.
- Institute of Structural Biology, Molecular Targets and Therapeutics Center, Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany.
- Institute of Biochemistry and Pathobiochemistry, Department of Systems Biochemistry, Faculty of Medicine, Ruhr-University Bochum, 44780 Bochum, Germany.
- Bavarian NMR Center, Department of Bioscience, TUM School of Natural Sciences, Technical University of Munich, Lichtenbergstrasse 4, 85747 Garching, Germany.
ORCID-Profile: Michał Nowacki, Filipe Menezes, Federico Ballabio, Valeria Napolitano, Chethan K Krishna, Grzegorz M Popowicz, Maciej Dawidowski
Förderung
- Narodowe Centrum Nauki
- Ruhr University Bochum, InnovationsFoRUM
- Bundesministerium für Bildung und Forschung
- Deutsche Forschungsgemeinschaft
- Deutsche Forschungsge-meinschaft
Zitieren
APA
Nowacki, M., Menezes, F., Dağdeviren, B., Ballabio, F., Napolitano, V., Krishna, C. K., Kalel, V. C., Erdmann, R., Sattler, M., Popowicz, G. M., & Dawidowski, M. (2026). Dibenzo[b,f]azocin-6(5H)-ones and Benzo[b]pyrido[2,3-f]azocin-5(6H)-ones: Useful Scaffolds for Development of Protein–Protein Interaction Inhibitors †. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27187998
Vancouver
Nowacki M, Menezes F, Dağdeviren B, Ballabio F, Napolitano V, Krishna CK, et al. Dibenzo[b,f]azocin-6(5H)-ones and Benzo[b]pyrido[2,3-f]azocin-5(6H)-ones: Useful Scaffolds for Development of Protein–Protein Interaction Inhibitors †. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27187998
BibTeX
@article{Nowacki2026,
author = {Nowacki, Michał and Menezes, Filipe and Dağdeviren, Başak and Ballabio, Federico and Napolitano, Valeria and Krishna, Chethan K and Kalel, Vishal C and Erdmann, Ralf and Sattler, Michael and Popowicz, Grzegorz M and Dawidowski, Maciej},
title = {Dibenzo[b,f]azocin-6(5H)-ones and Benzo[b]pyrido[2,3-f]azocin-5(6H)-ones: Useful Scaffolds for Development of Protein–Protein Interaction Inhibitors †},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27187998}
}
EUVIMED